Facebook Linkedin Twitter
Inside Precision Medicine Genomic Alterations Identified in Cutaneous T-Cell Lymphoma Could Provide Path to New Therapies

Non-hodgkin lymphoma

DNA sequence with colored letters on black background containing mutation
Molecular Dx

Genomic Alterations Identified in Cutaneous T-Cell Lymphoma Could Provide Path to New Therapies

0
Stop it
News & Features

FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial Hold

Alex Philippidis
0
Burkitt's lymphoma cells, is a cancer of the lymphatic system
News & Features

CAR T-Cell Therapy for High-Risk Lymphoma Makes Case as Standard-of-Care Treatment

Chris Anderson
0
T-cells attacking cancer cell illustration of microscopic photos
News & Features

Two-Step Process Allows CAR-T Therapy to Better Target Solid Tumors

0
RNA strands inside corona virus
Coronavirus

New SARS-CoV-2 Mutations Emerge in Patient with Cancer and COVID-19

0
brain tumor
News & Features

Biomarker-Guided Therapy for Newly Diagnosed Glioblastoma Kicks off Phase III Trial

0
T cells and cancer cells
News & Features

CAR T Cells Can Be Toggled On and Off, Say Dana-Farber Research Team

0
Marginal zone lymphoma, malignant B-cell
Molecular Dx

Celgene Taps ArcherDx for Diffuse Large B Cell Lymphoma Drug Candidate CDx

0
Clinical OMICs Magazine Volume 1, Issue No. 1
News & Features

Clinical OMICs Magazine Volume 1, Issue No. 1

0
123Page 3 of 3

Podcast Series

Behind the Breakthroughs

Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.

Related Content

Sage Publishing

Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.
Terms of ServicePrivacy Policy

Sage Publishing
Inside Precision Medicine